Capítulo 53 Diretrizes e Listas


53.1 Diretrizes

53.1.1 Quais são as diretrizes para relatórios estatísticos em pesquisas?

  • Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality.301

  • Review of guidance papers on regression modeling in statistical series of medical journals.408

  • Principles and recommendations for incorporating estimands into clinical study protocol templates.409

  • How to write statistical analysis section in medical research.236

  • A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.421

  • Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.410

  • Framework for the treatment and reporting of missing data in observational studies: The Treatment And Reporting of Missing data in Observational Studies framework.411

  • Guidelines for reporting of figures and tables for clinical research in urology.412

  • Who is in this study, anyway? Guidelines for a useful Table 1.198

  • Guidelines for Reporting of Statistics for Clinical Research in Urology.413

  • Reveal, Don’t Conceal: Transforming Data Visualization to Improve Transparency.205

  • Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.321

  • Basic statistical reporting for articles published in Biomedical Journals: The ‘’Statistical Analyses and Methods in the Published Literature’’ or the SAMPL Guidelines.414

  • Beyond Bar and Line Graphs: Time for a New Data Presentation Paradigm.415

  • STRengthening analytical thinking for observational studies: the STRATOS initiative.416

  • Research methods and reporting.417

  • How to ensure your paper is rejected by the statistical reviewer.418


53.2 Listas de verificação

53.2.1 Quais são as listas de verificação para relatórios estatísticos em pesquisas?

  • A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration.419

  • Checklist for clinical applicability of subgroup analysis.420

  • Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features.235



Citar como:
Ferreira, Arthur de Sá. Ciência com R: Perguntas e respostas para pesquisadores e analistas de dados. Rio de Janeiro: 1a edição,


Referências

198.
Hayes-Larson E, Kezios KL, Mooney SJ, Lovasi G. Who is in this study, anyway? Guidelines for a useful Table 1. Journal of Clinical Epidemiology. 2019;114:125–132. doi:10.1016/j.jclinepi.2019.06.011
205.
Weissgerber TL, Winham SJ, Heinzen EP, et al. Reveal, Don’t Conceal. Circulation. 2019;140(18):1506–1518. doi:10.1161/circulationaha.118.037777
235.
Dwivedi AK, Shukla R. Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features. CANCER REPORTS. 2019;3(4). doi:10.1002/cnr2.1211
236.
Dwivedi AK. How to Write Statistical Analysis Section in Medical Research. Journal of Investigative Medicine. 2022;70(8):1759–1770. doi:10.1136/jim-2022-002479
301.
Vickers AJ, Assel M, Dunn RL, et al. Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality. European Urology. 2023;84(2):147–151. doi:10.1016/j.eururo.2023.04.027
321.
Gamble C, Krishan A, Stocken D, et al. Guidelines for the Content of Statistical Analysis Plans in Clinical Trials. JAMA. 2017;318(23):2337. doi:10.1001/jama.2017.18556
408.
Wallisch C, Bach P, Hafermann L, et al. Review of guidance papers on regression modeling in statistical series of medical journals. Mathes T, org. PLOS ONE. 2022;17(1):e0262918. doi:10.1371/journal.pone.0262918
409.
Lynggaard H, Bell J, Lösch C, et al. Principles and recommendations for incorporating estimands into clinical study protocol templates. Trials. 2022;23(1). doi:10.1186/s13063-022-06515-2
410.
Althouse AD, Below JE, Claggett BL, et al. Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association. Circulation. 2021;144(4). doi:10.1161/circulationaha.121.055393
411.
Lee KJ, Tilling KM, Cornish RP, et al. Framework for the treatment and reporting of missing data in observational studies: The Treatment And Reporting of Missing data in Observational Studies framework. Journal of Clinical Epidemiology. 2021;134:79–88. doi:10.1016/j.jclinepi.2021.01.008
412.
Vickers AJ, Assel MJ, Sjoberg DD, et al. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. Urology. 2020;142:1–13. doi:10.1016/j.urology.2020.05.002
413.
Assel M, Sjoberg D, Elders A, et al. Guidelines for Reporting of Statistics for Clinical Research in Urology. Journal of Urology. 2019;201(3):595–604. doi:10.1097/ju.0000000000000001
414.
Lang TA, Altman DG. Basic statistical reporting for articles published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or the SAMPL Guidelines. International Journal of Nursing Studies. 2015;52(1):5–9. doi:10.1016/j.ijnurstu.2014.09.006
415.
Weissgerber TL, Milic NM, Winham SJ, Garovic VD. Beyond Bar and Line Graphs: Time for a New Data Presentation Paradigm. PLOS Biology. 2015;13(4):e1002128. doi:10.1371/journal.pbio.1002128
416.
Sauerbrei W, Abrahamowicz M, Altman DG, Cessie S, Carpenter J. STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative. Statistics in Medicine. 2014;33(30):5413–5432. doi:10.1002/sim.6265
417.
Groves T. Research methods and reporting. BMJ. 2008;337(oct22 1):a2201–a2201. doi:10.1136/bmj.a2201
418.
Stratton IM, Neil A. How to ensure your paper is rejected by the statistical reviewer. Diabetic Medicine. 2005;22(4):371–373. doi:10.1111/j.1464-5491.2004.01443.x
419.
Mansournia MA, Collins GS, Nielsen RO, et al. A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration. British Journal of Sports Medicine. 2021;55(18):1009–1017. doi:10.1136/bjsports-2020-103652
420.
Gil-Sierra MD, Fénix-Caballero S, Abdel kader-Martin L, et al. Checklist for clinical applicability of subgroup analysis. Journal of Clinical Pharmacy and Therapeutics. 2019;45(3):530–538. doi:10.1111/jcpt.13102
421.
Lee H, Cashin AG, Lamb SE, et al. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies. JAMA. 2021;326(11):1045. doi:10.1001/jama.2021.14075